Psychedelics Stocks $ENTBF - Time to Get in Early - Entheon BioMedical CEO Timothy Ko on the Positive Stocks Show

Summary: Entheon Biomedical (OTCMKTS: ENTBF) is a biotechnology company committed to the legal development of safe & effective psychedelic medicines in order to provide patients with access to evidence-based treatments for addiction disorders. Entheon Biomedical is a psychedelic research and drug development company focused on treating substance abuse disorders. We are addressing the lack of treatment options available to those suffering from addiction. Psychedelics have a long history in the treatment of addictive disorders[2], and we are working alongside a growing community of scientists and medical professionals to dispel and overcome the many misconceptions with respect to the clinical use of psychedelic medicines. Entheon Biomedical is investing in research with the aim to legally develop and commercialize a portfolio of psychedelic therapeutic products for the treatment of addictive disorders. https://entheonbiomedical.com/ Listen to CEOs, Entrepreneurs and Executives from public companies. For the investor, this podcast sits you down in front of some of the best companies in the world. Check out emerging growth and already established companies on the move. Subscribe to receive automatic updates from the Positive Stocks Podcast. https://www.positivestocks.com Disclaimer Penny stock trading involves substantial risk, so always research every alert before trading, only invest what you can afford to lose, and always trade with caution. Past performance does not guarantee future results. Individual investing results may and most likely will vary. Positive Stocks and its staff are not licensed investment advisors of any kind. This website and its reports are for general information purposes only as we are engaged in the business of marketing and advertising companies for monetary compensation. Learn more about the risks of investing in penny stocks at  www.sec.gov